Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia (301)
This study is ongoing, but not recruiting participants.
First Posted: September 28, 2012
Last Update Posted: April 28, 2017
The Leukemia and Lymphoma Society
Information provided by (Responsible Party):